KMC Speciality Hospitals (India) Ltd (KMCSHIL)

Loading page…

KMC Speciality Hospitals (India) Ltd (KMCSHIL) · mywealthgrid

About

KMC Speciality Hospitals operates specialty hospital facilities in India's private healthcare segment, with market cap ₹2,165.97 Cr and quarterly revenue around ₹30 Cr. The company demonstrated post-COVID recovery with strong operating margins of 24.56%, establishing a profitable position in the growing tertiary-care hospital services market.

Face value: ₹1

Market cap

₹2,804 Cr

P/E

219.4×

P/B

17.1×

Dividend yield

ROE

13.9%

ROCE

17.6%

Debt / equity

0.5

OPM

24.6%

EPS (TTM)

₹0.8

Book value

₹10.1

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Valuation risk: PE 169.49 with stock up 106% YoY and trading near 52w high (₹132.8 vs ₹140.65); verify earnings trajectory and margin sustainability.
Low institutional investor base: FII 0.02%, DII 0% suggests minimal analyst coverage and liquidity concerns for minority shareholders.
Capital intensity: Healthcare requires ongoing capex for beds and equipment; verify funding strategy and how margin gains translate to reinvestment.
Patient and payer concentration: Revenue mix of direct patients, insurance, and government schemes is not disclosed; verify stability against reimbursement changes.

Generated analysis · source review pending

Growth drivers

Recovery from ₹18.3 Cr (Jun 2020) to ₹29.93 Cr (Mar 2021) revenue; verify if driven by new capacity or utilization gains.
OPM expanded 11.15% (Jun 2020) to 28.96% (Mar 2021) showing cost absorption; verify if structural or pandemic-driven.
YoY revenue growth of 29% (Mar 2020–2021) indicates demand; verify capex plans and expansion feasibility.

Generated analysis · source review pending

2,310 historical price candles were omitted because the exchange source has not been verified.

₹171.9+6.1%1Y

Quick read

rule-based

Pros

+Strong return on equity of 21.4% (3-yr avg)
+High return on capital employed of 22.4%
+Healthy operating margin of 24.6%
+Revenue CAGR of 19.2% over the last 5 years
+High promoter holding of 75% with no pledge

Cons

−Expensive at 219.4× trailing earnings
−Trading at 17.1× book value

Research score

Structured signal from quality, growth, valuation and momentum.

39/100

Business quality: 48
Growth: 69

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	43	55	71	82	96	103	136	156	177	232
COGS	-6	-8	-10	-9	-14	16	21	23	24	34
Gross profit	—	—	—	—	—	86	116	133	153	198
	41	51	67	75	89	63	78	91	105	141
Operating profit (EBITDA)	8	12	14	16	21	23	37	41	47	57
OPM %	18.6%	21.8%	20%	19.5%	21.9%	22.6%	27.3%	26.5%	26.7%	24.6%
Depreciation	3	3	4	4	5	6	7	8	9	19
Interest	2	1	1	1	1	1	1	1	1	9
	1	0	0	2	1	2	2	3	4	3
Profit before tax	4	8	10	12	17	18	32	36	41	32
Tax	1	2	3	4	5	5	8	9	10	10
Tax %	20.7%	22.3%	32.1%	30.2%	29.7%	29.2%	26.1%	25.8%	25.1%	32.2%
	3	6	7	9	12	13	24	27	30	21
PAT margin %	7.5%	10.9%	9.4%	10.5%	12.2%	12.5%	17.4%	17.1%	17.2%	9.3%
EPS (₹)	0.2	0.4	0.4	0.5	0.7	0.8	1.5	1.6	1.9	1.3
EPS adjusted (₹)	—	—	—	—	0.7	0.8	1.5	1.6	1.9	1.3
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity capital	16	16	16	16	16	16
Reserves	—	47	70	97	127	148
	—	27	27	45	72	82
	—	15	15	24	48	40
Total equity & liabilities	—	105	129	182	264	286
	38	72	73	79	196	240
CWIP	—	2	6	34	1	0
Investments	—	0	0	0	0	0
	—	31	49	68	67	46
Total assets	—	105	129	182	264	286

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	26	29	32	38	58
	-43	-29	-48	-56	-51
	18	-1	16	21	-2
Net cash flow	1	-0	0	3	4
Free cash flow	-15	16	-12	-37	-6
CFO / Operating profit %	110.2%	78.3%	78.2%	81.1%	101.2%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Margins
Gross margin %	—	—	—	84.1%	84.9%	85.3%	86.2%	85.5%
EBITDA margin %	20%	19.5%	21.9%	22.6%	27.3%	26.5%	26.7%	24.6%
EBIT margin %	14.5%	14.3%	16.8%	16.6%	22.5%	21.6%	21.5%	16.4%
PAT margin %	9.4%	10.5%	12.2%	12.5%	17.4%	17.1%	17.2%	9.3%
Working capital
Receivable days	—	—	—	9	9	10	9	9
Inventory days	—	—	—	39	33	36	31	38
Payable days	—	—	—	117	96	102	80	153
NWC days	—	—	—	-68	-53	-56	-40	-105
Leverage
Current ratio	—	—	—	2.27	2.3	2.37	0.72	0.88
Debt to EBITDA	—	—	—	1.16	0.72	1.08	1.53	1.44
Debt to equity	—	—	—	0.43	0.31	0.39	0.5	0.5
Interest coverage	13.4	12.1	20.4	20	46.9	45.4	36	4.4
Asset turnover	—	—	—	0.98	1.06	0.86	0.67	0.81
Return ratios
Return on assets %	—	—	—	12.2%	18.4%	14.7%	11.5%	7.5%
Return on capital employed %	—	—	—	20.5%	32.5%	27.4%	22.2%	17.6%
Return on equity %	—	—	—	20.2%	27.3%	23.5%	21.2%	13%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	75%	75%	75%	75%	75%	75%	75%	75%	75%	75%	75%	75%
	0%	0%	0%	0%	0%	0%	0.01%	0%	0%	0%	0%	0.02%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	25%	25%	25%	25%	25%	25%	24.99%	25%	25%	25%	25%	24.98%
No. of shareholders	—	—	—	—	—	—	—	—	86,958	86,344	86,318	88,487

Promoter holding up 0 percentage points since Sep 2023.

Mr. Chandrakumar SExecutive Director-Chairperson
Mr. Selvaraj ManivannanExecutive Director-MD
Mr. Thirunavukarasu SenthilkumarNon-Executive - Non Independent Director
Mr. Sundararaju VijayabaskaranNon-Executive - Non Independent Director
Mr. Sunil Satyapal GulatiNon-Executive - Independent Director
Mr. Purushothaman RavichandranNon-Executive - Independent Director
Mr. Srinivasan MohanNon-Executive - Independent Director
Mrs. Narayanasami JeyantheiNon-Executive - Independent Director
Mr. K Anand BabuChief Financial Officer
Ms. Indumathi PCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 1 fund houses

Held by these funds

of the company's equity

All mutual funds

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

1 schemes

		Shares
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	1,074	0.01	0.03%	0.001%	+2

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results14 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

16 announcementsExport CSV

3 Sept 2026, 5:38 pmAGM/EGM

Notice Of 43Rd Annual General Meeting To Be Held On Monday, September 28, 2026, At 10:30 A.M. IST Through Video Conference (VC) / Other Audio Visual Means (OAVM).

AGM PDF

28 Aug 2026, 4:19 pmCompany Update

Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation PDF

20 Aug 2026, 6:15 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

14 Aug 2026, 11:51 amCompany Update

Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Intimation Of Capacity Addition & Cost Auditor Appointment

General PDF

14 Aug 2026, 11:38 amResult

Standalone Unaudited Financial Results For The Quarter Ended 30Th June, 2026

Financial Results PDF

14 Aug 2026, 11:33 amBoard Meeting

Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th August, 2026

Outcome of Board Meeting PDF

10 Aug 2026, 3:51 pmBoard Meeting

Board Meeting Intimation for Board Meeting Scheduled To Be Held On 14Th August, 2026

Exchange filing PDF

7 Jul 2026, 3:17 pmCompany Update

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 PDF

Date	Category	Subject	Filing
3 Sept 2026, 5:38 pm	AGM/EGM AGM	Notice Of 43Rd Annual General Meeting To Be Held On Monday, September 28, 2026, At 10:30 A.M. IST Through Video Conference (VC) / Other Audio Visual Means (OAVM).	PDF
28 Aug 2026, 4:19 pm	Company Update Investor Presentation	Announcement under Regulation 30 (LODR)-Investor Presentation

Loading announcements…

Ratio	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Margins
Gross margin %	—	—	—	84.1%	84.9%	85.3%	86.2%	85.5%
EBITDA margin %	20%	19.5%	21.9%	22.6%	27.3%	26.5%	26.7%	24.6%
EBIT margin %	14.5%	14.3%	16.8%	16.6%	22.5%	21.6%	21.5%	16.4%
PAT margin %	9.4%	10.5%	12.2%	12.5%	17.4%	17.1%	17.2%	9.3%
Working capital
Receivable days	—	—	—	9	9	10	9	9
Inventory days	—	—	—	39	33	36	31	38
Payable days	—	—	—	117	96	102	80	153
NWC days	—	—	—	-68	-53	-56	-40	-105
Leverage
Current ratio	—	—	—	2.27	2.3	2.37	0.72	0.88
Debt to EBITDA	—	—	—	1.16	0.72	1.08	1.53	1.44
Debt to equity	—	—	—	0.43	0.31	0.39	0.5	0.5
Interest coverage	13.4	12.1	20.4	20	46.9	45.4	36	4.4
Asset turnover	—	—	—	0.98	1.06	0.86	0.67	0.81
Return ratios
Return on assets %	—	—	—	12.2%	18.4%	14.7%	11.5%	7.5%
Return on capital employed %	—	—	—	20.5%	32.5%	27.4%	22.2%	17.6%
Return on equity %	—	—	—	20.2%	27.3%	23.5%	21.2%	13%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

KMC Speciality Hospitals (India) Ltd

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

1

Announcements

Not in the F&O segment

1

Announcements

Annual reports

Credit ratings

Compounded sales growth

Compounded profit growth

Return on equity

KMC Speciality Hospitals (India) Ltd

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Board meetings1

Announcements

Ratio timeline

Quarterly record

Board and management

Not in the F&O segment

Board meetings1

Announcements

Annual reports

Credit ratings

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1